BR112012029225A2 - processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral - Google Patents

processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral

Info

Publication number
BR112012029225A2
BR112012029225A2 BR112012029225A BR112012029225A BR112012029225A2 BR 112012029225 A2 BR112012029225 A2 BR 112012029225A2 BR 112012029225 A BR112012029225 A BR 112012029225A BR 112012029225 A BR112012029225 A BR 112012029225A BR 112012029225 A2 BR112012029225 A2 BR 112012029225A2
Authority
BR
Brazil
Prior art keywords
chiral compound
preparation
chiral
compound
Prior art date
Application number
BR112012029225A
Other languages
English (en)
Other versions
BR112012029225B1 (pt
Inventor
Dominic De Souza
Jörg Salchenegger
Martin Albert
Michael Oberhuber
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of BR112012029225A2 publication Critical patent/BR112012029225A2/pt
Publication of BR112012029225B1 publication Critical patent/BR112012029225B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C241/00Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C241/04Preparation of hydrazides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/28Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • C07C251/74Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/76Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/188Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR112012029225-0A 2010-05-19 2011-05-18 processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral BR112012029225B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10163212 2010-05-19
EP10163212.3 2010-05-19
PCT/EP2011/058035 WO2011144655A1 (en) 2010-05-19 2011-05-18 Process for the preparation of chiral hydrazides

Publications (2)

Publication Number Publication Date
BR112012029225A2 true BR112012029225A2 (pt) 2016-11-29
BR112012029225B1 BR112012029225B1 (pt) 2020-10-27

Family

ID=42710570

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012029225-0A BR112012029225B1 (pt) 2010-05-19 2011-05-18 processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral

Country Status (10)

Country Link
US (1) US9199919B2 (pt)
EP (1) EP2571847B1 (pt)
JP (1) JP5956980B2 (pt)
CN (1) CN102892750B (pt)
AU (1) AU2011254656B2 (pt)
BR (1) BR112012029225B1 (pt)
CA (1) CA2797999C (pt)
MX (1) MX337804B (pt)
RU (1) RU2588570C2 (pt)
WO (1) WO2011144655A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX342850B (es) 2010-05-19 2016-10-14 Sandoz Ag Proceso para la preparacion de triazolonas quirales.
EP2571868B1 (en) 2010-05-19 2016-05-04 Sandoz AG Preparation of posaconazole intermediates
BR112012029228A2 (pt) 2010-05-19 2021-08-03 Sandoz Ag processo para a preparação de um sal de cloreto de hidrogênio, sal de cloreto de hidrogênio, sal de cloreto de hidrogênio cristalino, uso de um sal e uso do processo
CN103635465A (zh) 2011-06-16 2014-03-12 桑多斯股份公司 制备手性化合物的方法
EP2789610A1 (en) 2013-04-10 2014-10-15 Sandoz Ag Purification of Posaconazole Intermediates
CN105622464A (zh) * 2015-12-21 2016-06-01 上海同昌生物医药科技有限公司 一种手性肼的制备方法
CN105618135B (zh) * 2016-01-10 2018-01-16 沧州普瑞东方科技有限公司 一种手性cbs催化剂的制备方法
CN111323493A (zh) * 2018-12-14 2020-06-23 武汉赛沃医药科技有限公司 一种泊沙康唑起始物料对映异构体的检测方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
IL103558A0 (en) 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
FR2706456B1 (fr) * 1993-06-18 1996-06-28 Rhone Poulenc Agrochimie Dérivés optiquement actifs de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
US5595872A (en) 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
US5403937A (en) 1993-04-30 1995-04-04 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
US5349099A (en) 1993-12-13 1994-09-20 Schering Corporation Process for preparing intermediates for the synthesis of antifungal agents
US5710154A (en) 1993-12-21 1998-01-20 Schering Corporation Tetrahydrofuran antifungals
US5714490A (en) 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
CZ294823B6 (cs) 1993-12-21 2005-03-16 Schering Corporation Fungicidní tetrahydrofurany
US5693626A (en) 1993-12-21 1997-12-02 Schering Corporation Tetrahydrofuran antifungals
NZ270418A (en) 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
US5486625A (en) 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
US5616777A (en) 1995-04-19 1997-04-01 Schering Corporation Chiral hydrazine derivatives
US5625064A (en) 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
AR002751A1 (es) 1995-06-02 1998-04-29 Schering Corp Antifungicos de tetrahidrofurano, composiciones farmaceuticas que los contienen y el uso de los compuestos para preparar composiciones farmaceuticas utiles para el tratamiento de infecciones fungicas
WO1997000255A1 (en) 1995-06-19 1997-01-03 Schering Corporation Tetrahydrofuran antifungals
KR100456181B1 (ko) 1995-12-20 2004-12-31 쉐링 코포레이션 항진균제합성용중간체의제조방법
SK85998A3 (en) 1995-12-20 1999-02-11 Schering Corp Process for preparation of hydrazides
EP0885394B1 (de) 1996-03-08 2000-08-16 Octapharma AG Verfahren zur eignungsprüfung von faktor viii-haltigen proteinfraktionen
US5834472A (en) 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5972381A (en) 1996-06-28 1999-10-26 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability
ZA989063B (en) 1997-10-07 1999-04-06 Schering Corp Crystalline antifungal polymorph
US6713481B1 (en) 1997-10-17 2004-03-30 David R. Andrews Crystalline antifungal polymorph
US6355801B1 (en) 1999-11-08 2002-03-12 Schering Corporation Process for preparing N-(4-hydroxyphenyl)-N′-(4′-aminophenyl)-piperazine
AU1465301A (en) 1999-11-08 2001-06-06 Schering Corporation Process for preparing n-(4-hydroxy-phenyl)-n'-(4'-aminophenyl)-piperazine
AU2002257104B2 (en) 2001-04-03 2006-02-09 Merck Sharp & Dohme Corp. Antifungal composition with enhanced bioavailability
JP4617114B2 (ja) * 2003-08-25 2011-01-19 学校法人東京理科大学 光学活性α−アミノオキシケトン誘導体及びその製造方法
US20090099364A1 (en) 2004-02-02 2009-04-16 Pfizer Inc. Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5- tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
CA2567803A1 (en) 2004-05-28 2005-12-15 Schering Corporation Injectable pharmaceutical suspension comprising posaconazole
MY142804A (en) 2004-07-01 2011-01-14 Opko Health Inc Nk1 antagonists
CN1709870B (zh) * 2005-07-19 2011-07-06 中国科学院成都生物研究所 光学纯n′,n′-二取代脯氨酰肼化合物及其制备方法和应用
BRPI0710156A2 (pt) 2006-04-20 2012-06-05 Glaxo Group Ltd composto ou um sal do mesno, composição, combinação, e, uso de um composto.
SG170047A1 (en) 2006-05-30 2011-04-29 Elan Pharma Int Ltd Nanoparticulate posaconazole formulations
CN102702185A (zh) 2007-04-27 2012-10-03 卫材R&D管理有限公司 杂环取代吡啶衍生物的盐的结晶
CA2703257C (en) 2007-10-29 2013-02-19 Amgen Inc. Benzomorpholine derivatives and methods of use
WO2009129297A1 (en) 2008-04-15 2009-10-22 Schering Corporation Semi-solid oral pharmaceutical compositions
WO2009141837A2 (en) 2008-05-21 2009-11-26 Ind-Swift Laboratories Limited Process for preparing posaconazole and intermediates thereof
EP2130540A1 (en) * 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
AU2009339445A1 (en) 2009-02-05 2011-08-18 Targeted Delivery Technologies Limited Methods of reducing the proliferation and viability of microbial agents
BR112012029228A2 (pt) 2010-05-19 2021-08-03 Sandoz Ag processo para a preparação de um sal de cloreto de hidrogênio, sal de cloreto de hidrogênio, sal de cloreto de hidrogênio cristalino, uso de um sal e uso do processo
EP2571868B1 (en) 2010-05-19 2016-05-04 Sandoz AG Preparation of posaconazole intermediates
MX342850B (es) 2010-05-19 2016-10-14 Sandoz Ag Proceso para la preparacion de triazolonas quirales.
WO2013186320A1 (en) 2012-06-14 2013-12-19 Sandoz Ag Pharmaceutical composition comprising crystalline posaconazole

Also Published As

Publication number Publication date
EP2571847B1 (en) 2016-09-21
US9199919B2 (en) 2015-12-01
AU2011254656B2 (en) 2015-04-16
BR112012029225B1 (pt) 2020-10-27
MX337804B (es) 2016-03-18
RU2012154810A (ru) 2014-06-27
JP5956980B2 (ja) 2016-07-27
CA2797999C (en) 2019-07-09
WO2011144655A1 (en) 2011-11-24
MX2012013333A (es) 2013-02-01
RU2588570C2 (ru) 2016-07-10
CA2797999A1 (en) 2011-11-24
CN102892750A (zh) 2013-01-23
AU2011254656A1 (en) 2012-12-20
JP2013530946A (ja) 2013-08-01
US20130203993A1 (en) 2013-08-08
CN102892750B (zh) 2016-03-02
EP2571847A1 (en) 2013-03-27

Similar Documents

Publication Publication Date Title
BR112014001418A2 (pt) compostos, processo para a preparação dos compostos, e, uso dos compostos
BRPI0908252A2 (pt) Processo para preparar um composto, e, uso de um composto
BR112012019936A2 (pt) uso de um composto, método de preparação de um composto, método e composto
BR112014000260A2 (pt) composto, e, uso de um composto
BRPI0911254A2 (pt) processo para a preparação de um composto
BRPI0916609A2 (pt) Processo para a preparação de um macrociclo
BR112013009486A2 (pt) processo para preparação de formas de dosagem gastrirretentivas multiparticuladas
BRPI1010933A2 (pt) processo para a preparação de um pó, e, composto
BR112013030163A2 (pt) composto, uso cosmético de pelo menos um composto, composição farmacêutica ou cosmética e processo para preparar um composto.
BR112014008196A2 (pt) processo para a preparação de um composto
BR112013028959A2 (pt) composto, processo para o preparo de um composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
BRPI0908738A2 (pt) composto, medicamento, uso de um composto, e, processo para preparar os compostos
BR112012029226A2 (pt) processo para a preparação de um composto quiral, composto quiral cristalino, sal de hcl do composto quiral cristalino, composto quiral e uso do composto
BRPI1010147A2 (pt) processo para preparar um composto, uso de um processo e uso de um catalisador de irídio
BR112012029225A2 (pt) processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral
BR112013010075A2 (pt) compostos intermediários e processo para a preparação de fingolimod
BRPI0911897A2 (pt) Processo para a preparação de compostos, e, composto
BR112013008008A2 (pt) composto, composição farmacêutica e processo para preparar um composto
BR112015003101A2 (pt) processo para a preparação de um composto.
BR112013029206A2 (pt) composto, e, uso de um composto
BR112014013354A2 (pt) processo para a preparação de um polímero, composição, composto, e, formulação
BRPI0813438A2 (pt) Processo para preparar um composto, uso de um composto, e, composto.
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
BR112014009684A2 (pt) processo para preparar polímeros, polímero e uso de polímeros
BR112013032690A2 (pt) método para produzir um composto, composto, e, uso do mesmo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/05/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 12A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2724 DE 21-03-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.